Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Post by bealerton Jul 03, 2021 12:24pm
257 Views
Post# 33489641

Transperance - You stated it quite well.

Transperance - You stated it quite well.Management impresses only each other on what a fine job they are doing, hence the bonuses.
In a normal world you would only get bonuses once you show the money.  Vanc. shytshows have little responsibility or accountability to shareholders.  I was told they read Stockhouse, and if they do, they are sure some dumb and dense as they seldom do what produces results or try to difuse shareholder skepticism.  They are like wet noodles and let the other party dictate the terms and then tell us that it's a secret and that biotech takes waaaaaaaay longer than one thinks.  That's because they are not in the drivers' seat and are intimidated by the big boys so that the big boys get control of the would-be deals.

Come on Sirona Mgmt., shyt or get off the pot.  Everyone is tired of dealing with your unconfessed failures.  You are doing what keeps us out of the hands of the SEC but we need you to go the extra mile that produces deals.  We need REAL revenue, not dilution or loans.  We have the product!

Speaking of product, we have less than zero information on how R + F are doing with sales or acceptance.  It has been months now and not a word.  How encouraging!

Happy weekend everyone from BeAlert
<< Previous
Bullboard Posts
Next >>